
In the latest Alzheimer’s news, Eli Lilly’s, Solanezumub, (where do they get these drug names?)shows some hope for mild cases of Alzheimer’s, but not for more advanced cases. The drug is not due for FDA approval any time soon because its goal was to aggressively alter the destruction of Alzheimer’s for the more advanced cases. That goal has [...]